ArticleBlood2024
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.
Kyumin Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleBlood2024
Kyumin Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.